Consolidated Statements of Convertible Preferred Stock and Changes In Stockholders' Equity (Deficit) - USD ($) $ in Thousands		Total	Convertible Preferred Stock	Preferred Stock Convertible Preferred Stock	Common Stock		Additional Paid-in Capital	Notes Receivable from Related Parties	Accumulated Deficit	Accumulated Other Comprehensive Loss
Balance, before retroactive conversion		$ (49,896)		$ 46,370	$ 2		$ 5,383	$ (103)	$ (55,178)
Retroactive application					$ (1)		1
Retroactive application, shares	[1]			(126,942,949)	(15,778,049)
Balance, before retroactive conversion, shares	[1]			165,578,120	20,580,109
Beginning balance at Dec. 31, 2021		(49,896)		$ 46,370	$ 1		5,384	(103)	(55,178)
Beginning balance, shares at Dec. 31, 2021	[1]			38,635,171	4,802,060
Issuance of common stock upon exercise of stock options		325					325
Issuance of common stock upon exercise of stock options, shares	[1]				667,861
Stock-based compensation expense		813					813
Proceeds from sale of Series E, net of issuance costs				$ 40,770
Proceeds from sale of Series E, net of issuance costs, shares	[1]			7,832,394
Forgiveness of recourse note to purchase common stock, value		103						$ 103
Net loss		(7,037)							(7,037)
Ending balance at Dec. 31, 2022		(55,692)		$ 87,140	$ 1		6,522		(62,215)
Ending balance, shares at Dec. 31, 2022	[1]			46,467,565	5,469,921
Issuance of common stock upon exercise of stock options		$ 215					215
Issuance of common stock upon exercise of stock options, shares		433,915			433,906	[1]
Stock-based compensation expense		$ 3,808					3,808
Issuance of common stock in connection with the acquisition of fSight		10,077					10,077
Issuance of common stock in connection with the acquisition of fSight, shares	[1]				1,306,385
Purchase price adjustment in connection with the fSight acquisition		898					898
Forfeitures of restricted stock and restricted stock surrendered in lieu of withholding taxes		(91)					(91)
Forfeitures of restricted stock and restricted stock surrendered in lieu of withholding taxes, shares	[1]				(11,832)
Convertible preferred stock dividends							12,581		(12,581)
Convertible preferred stock dividends, shares	[1]			1,258,055
Issuance of preferred stock upon exercise of preferred warrants		2,008					2,008
Issuance of preferred stock upon exercise of preferred warrants, shares	[1]			193,372
Conversion of convertible preferred stock into common stock in connection with the Business Combination		87,140	$ (87,140)		$ 5		87,135
Conversion of convertible preferred stock into common stock in connection with the Business Combination, shares	[1]		(47,918,992)		47,918,992
Issuance of common stock upon exercise of common warrants, shares	[1]				1,491,229
Stock Issued During Period, Shares, Acquisitions	[1]				1,306,385
Issuance of common stock upon Business Combination, shares	[1]				1,818,519
Issuance of common stock upon Business Combination, value		573					573
Issuance of common stock upon exercise of common stock warrants, net of issuance costs and payments to warrant holders of non-redeemed warrants		3,653					3,653
Issuance of common stock upon exercise of common stock warrants, net of issuance costs and payments to warrant holders of non-redeemed warrants, shares	[1]				324,546
Reclassification of convertible note derivative liability to equity		11,278					11,278
Unrealized gain (loss) resulting from change in fair value of marketable securities		(59)								$ (59)
Net loss		(984)							(984)
Ending balance at Dec. 31, 2023		$ 62,824			$ 6		$ 138,657		$ (75,780)	$ (59)
Ending balance, shares at Dec. 31, 2023	[1]				58,751,666

[1] The shares of the Company’s common and redeemable convertible preferred stock prior to the Business Combination (as defined in Note 1) have been retroactively restated to reflect the exchange ratio of approximately 0.233335 established in the Business Combination as described in Note 3.